JUAN FRANCISCO ASCASO GIMILIO-rekin lankidetzan egindako argitalpenak (142)

2022

  1. Beneficial effects of PCSK9 inhibition with alirocumab in familial hypercholesterolemia involve modulation of new immune players

    Biomedicine and Pharmacotherapy, Vol. 145

  2. Corticotroph cell hyperplasia as a rare cause of ACTH-dependent Cushing syndrome

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 9, pp. 694-701

2021

  1. Hypotriglyceridemias/hypolipidemias

    Clinica e Investigacion en Arteriosclerosis, Vol. 33, pp. 63-68

  2. Lipid metabolism and classification of hyperlipaemias

    Clinica e Investigacion en Arteriosclerosis, Vol. 33, pp. 3-9

  3. Oral Unsaturated Fat Load Impairs Postprandial Systemic Inflammation in Primary Hypercholesterolemia Patients

    Frontiers in Pharmacology, Vol. 12

  4. Peripheral blood levels of CXCL10 are a useful marker for diabetic polyneuropathy in subjects with type 2 diabetes

    International Journal of Clinical Practice, Vol. 75, Núm. 8

  5. Postprandial triglyceridaemia is modulated by insulin resistance but not by grade of obesity in abdominal and morbid obese subjects

    International Journal of Clinical Practice, Vol. 75, Núm. 4

2020

  1. Gender differences on oxidative stress markers and complement component C3 plasma values after an oral unsaturated fat load test

    Clínica e investigación en arteriosclerosis, Vol. 32, Núm. 3, pp. 87-93

  2. Gender differences on oxidative stress markers and complement component C3 plasma values after an oral unsaturated fat load test

    Clinica e Investigacion en Arteriosclerosis, Vol. 32, Núm. 3, pp. 87-93

2019

  1. Changes in CDKN2A/2B expression associate with T-cell phenotype modulation in atherosclerosis and type 2 diabetes mellitus

    Translational Research, Vol. 203, pp. 31-48

  2. Gene expression profile following an oral unsaturated fat load in abdominal obese subjects

    European Journal of Nutrition, Vol. 58, Núm. 3, pp. 1331-1337

  3. Novel immune features of the systemic inflammation associated with primary hypercholesterolemia: Changes in cytokine/chemokine profile, increased platelet and leukocyte activation

    Journal of Clinical Medicine, Vol. 8, Núm. 1

  4. Standards for global cardiovascular risk management arteriosclerosis

    Clinica e Investigacion en Arteriosclerosis, Vol. 31, pp. 1-43

  5. Systemic inflammation in metabolic syndrome: Increased platelet and leukocyte activation, and key role of CX3 CL1/CX3 CR1 and CCL2/CCR2 axes in arterial platelet-proinflammatory monocyte adhesion

    Journal of Clinical Medicine, Vol. 8, Núm. 5

  6. Type 1 diabetic mellitus patients with increased atherosclerosis risk display decreased CDKN2A/2B/2BAS gene expression in leukocytes

    Journal of Translational Medicine, Vol. 17, Núm. 1

2018

  1. Actualización del abordaje terapéutico del paciente con dislipemia.

    Esmon Publicidad

  2. Actualización del abordaje terapéutico del paciente con dislipemia.

    Esmon Publicidad

  3. Autosomal Recessive Hypercholesterolemia: Long-Term Cardiovascular Outcomes

    Journal of the American College of Cardiology, Vol. 71, Núm. 3, pp. 279-288

  4. Functional role of endothelial CXCL16/ CXCR6-platelet–leucocyte axis in angiotensin II-associated metabolic disorders

    Cardiovascular Research, Vol. 114, Núm. 13, pp. 1764-1775

  5. Hypercholesterolemia

    Encyclopedia of Endocrine Diseases (Elsevier), pp. 320-326